Daniel A. Stevens

Daniel A. Stevens

Auto-generated profile, based on publicly available information

Daniel A. Stevens

From the Department of Neuroradiology (R.D., M.W.), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Radiology (P.A.), University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, Ohio, USA; Department of Psychiatry and Behavioral Sciences (D.A.S.), and Russel H. Morgan Department of Radiology and Radiological Science (H.I.S., V.Y., L.P.L.). Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Brain Communications
Verified
Journal Article
Open access
PDF file
DSDaniel A. Stevens
Daniel A. Stevens
CWClifford I. Workman
Clifford I. Workman
HKHiroto Kuwabara
Hiroto Kuwabara
MBMeryl A. Butters
Meryl A. Butters
ASAlena Savonenko
Alena Savonenko
GSGwenn S. Smith
Gwenn S. Smith
Beta-amyloid deposition is one of the earliest pathological markers associated with Alzheimer's disease. Mild cognitive impairment in the setting of beta-amyloid deposition is considered to represent a preclinical manifestation of Alzheimer's disease. In vivo imaging studies are unique in their potential to advance our understanding of the role of beta-amyloid deposition in cognitive deficits in Alzheimer's disease and in mild cognitive impairment. Previous work has shown an association between global cortical measures of beta-amyloid deposition (‘amyloid positivity’) in mild cognitive impairment with greater cognitive deficits and greater risk of progression to Alzheimer's disease. The focus of the present study was to examine the relationship between the regional distribution of beta-amyloid deposition and specific cognitive deficits in people with mild cognitive impairment and cognitively normal elderly individuals. Forty-seven participants with multi-domain, amnestic mild cognitive impairment (43% female, aged 57–82 years) and 37 healthy, cognitively normal comparison subjects (42% female, aged 55–82 years) underwent clinical and neuropsychological assessments and high-resolution positron emission tomography with the radiotracer 11C-labelled Pittsburgh compound B to measure beta-amyloid deposition. Brain–behaviour partial least-squares analysis was conducted to identify spatial patterns of beta-amyloid deposition that correlated with the performance on neuropsychological assessments. Partial least-squares analysis identified a single significant (P < 0.001) latent variable which accounted for 80% of the covariance between demographic and cognitive measures and beta-amyloid deposition. Performance in immediate verbal recall (R = −0.46 ± 0.07, P < 0.001), delayed verbal recall (R = −0.39 ± 0.09, P < 0.001), immediate visual-spatial recall (R = −0.39 ± 0.08, P < 0.001), delayed visual-spatial recall (R = −0.45 ± 0.08, P < 0.001) and semantic fluency (R = −0.33 ± 0.11, P = 0.002) but not phonemic fluency (R = −0.05 ± 0.12, P < 0.705) negatively covaried with beta-amyloid deposition in the identified regions. Partial least-squares analysis of the same cognitive measures with grey matter volumes showed similar associations in overlapping brain regions. These findings suggest that the regional distribution of beta-amyloid deposition and grey matter volumetric decreases is associated with deficits in executive function and memory in mild cognitive impairment. Longitudinal analysis of these relationships may advance our understanding of the role of beta-amyloid deposition in relation to grey matter volumetric decreases in cognitive decline.

23 May 2022 in Journal of the Academy of Consultation-Liaison Psychiatry
Verified
Journal Article
Closed access
BBBarry R. Bryant
Barry R. Bryant
LRLisa N. Richey
Lisa N. Richey
SJSahar Jahed
Sahar Jahed
AHAmanda Heinzerling
Amanda Heinzerling
DSDaniel A. Stevens
Daniel A. Stevens
NTNicholas T. Trapp
Nicholas T. Trapp

10 February 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
RDRichard Dagher
Richard Dagher
PAParisa Arjmand
Parisa Arjmand
DSDaniel A. Stevens
Daniel A. Stevens
MWMax Wintermark
Max Wintermark
HSHaris Iqbal Sair
Haris Iqbal Sair
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
BACKGROUND AND PURPOSE: PTSD has been linked to an increased risk of cognitive impairment and dementia, with neuroinflammation, metabolic dysfunction, and neuropathological markers such as beta-amyloid and tau implicated as potential mechanisms. However, the roles of altered functional connectivity and amyloid deposition as biomarkers in the progression of cognitive impairment among PTSD patients remain unclear, with limited and often conflicting evidence from existing neuroimaging studies. This study examines these neuroimaging markers in PTSD patients with and without cognitive impairment to better understand the neurobiological pathways contributing to cognitive decline in PTSD. MATERIALS AND METHODS: Data were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Department of Defense (DOD) ADNI databases. A cohort of 178 age-matched male subjects was divided into four groups: PTSD with cognitive impairment (CI) (PTSD-CI); PTSD and cognitively normal (CN) (PTSD-CN); non-PTSD (NPTSD with CI (NPTSD-CI); and NPTSD and CN (NPTSD-CN). All subjects underwent resting-state functional MRI and amyloid PET imaging, with PTSD diagnosis and CI confirmed through clinical assessments. Functional connectivity was analyzed using the CONN Toolbox, and amyloid burden was quantified via standardized uptake value ratios. Analyses controlled for demographic and genetic factors, including age, education, APOE4 status, and depression. RESULTS: Compared to the NPTSD-CN group, the PTSD-CI group showed significantly increased amyloid uptake in the temporal and parietal lobes, with corresponding functional connectivity increase between the bilateral temporal lobes and parietal operculum. In contrast, PTSD-CN patients exhibited no significant amyloid increase but showed increased connectivity between the salience network, postcentral gyri and sensorimotor areas, and decreased connectivity between the sensorimotor network and anterior cingulate cortex. These distinct patterns suggest differing neurobiological profiles between PTSD-CI and PTSD-CN patients. CONCLUSIONS: The findings suggest that elevated amyloid and altered connectivity patterns are associated with CI in PTSD, particularly in the temporal and parietal regions. In contrast, PTSD without cognitive decline was associated with functional connectivity changes in salience and sensorimotor networks but no increased amyloid deposition. This study underscores the importance of neuroimaging biomarkers in understanding PTSD-related cognitive decline and suggests avenues for further investigation into the mechanistic pathways involved. ABBREVIATIONS: ACC = anterior division of the cingulate gyrus; ADAS-Cog = Alzheimer’s Disease Assessment Scale-Cognitive; CAPS = Clinician-Administered PTSD Scale; PTSD = post-traumatic stress disorder; CI = cognitively impaired; CN = cognitively normal; ECog = Everyday Cognition; GDS = Geriatric Depression Scale; MoCA = Montreal Cognitive Assessment; NPTSD = non-PTSD.

14 September 2021 in Journal of the Academy of Consultation-Liaison Psychiatry
Verified
Journal Article
Closed access
SJSahar Jahed
Sahar Jahed
NDNicholas O. Daneshvari
Nicholas O. Daneshvari
ALAngela L. Liang
Angela L. Liang
LRLisa N. Richey
Lisa N. Richey
BBBarry R. Bryant
Barry R. Bryant
MPMatthew E. Peters
Matthew E. Peters

1 January 2022 in Journal of Concussion
Verified
Journal Article
Open access
LRLisa N. Richey
Lisa N. Richey
BBBarry R. Bryant
Barry R. Bryant
AKAkshay Krieg
Akshay Krieg
MBMichael J. C. Bray
Michael J. C. Bray
AEAaron I. Esagoff
Aaron I. Esagoff
MPMatthew E. Peters
Matthew E. Peters
Objective: To complete a systematic review of the literature examining neuroimaging findings unique to co-occurring syndromal depression in the setting of TBI. Methods: A PRISMA compliant literature search was conducted in PubMed (MEDLINE), PsychINFO, EMBASE, and Scopus databases for articles published prior to April of 2022. The database query yielded 4447 unique articles. These articles were narrowed based on specific inclusion criteria (e.g., clear TBI definition, clear depression construct commenting on the syndrome of major depressive disorder, conducted empirical analyses comparing neuroimaging correlates in TBI subjects with depression versus TBI subjects without depression, controlled for the time interval between TBI occurrence and acquisition of neuroimaging). Results: A final cohort of 10 articles resulted, comprising the findings from 423 civilians with brain injury, 129 of which developed post-TBI depression. Four articles studied mild TBI, three mild/moderate, one moderate/severe, and two all-comers, with nine articles focusing on single TBI and one including both single and recurrent injuries. Spatially convergent structural abnormalities in individuals with TBI and co-occurring syndromal depression were identified primarily in bilateral frontal regions, particularly in those with damage to the left frontal lobe and prefrontal cortices, as well as temporal regions including bilateral temporal lobes, the left superior temporal gyrus, and bilateral hippocampi. Various parietal regions and the nucleus accumbens were also implicated. EEG studies showed supporting evidence of functional changes in frontal regions. Conclusion: Additional inquiry with attention to TBI without depression control groups, consistent TBI definitions, previous TBI, clinically diagnosed syndromal depression, imaging timing post-injury, acute prospective design, functional neuroimaging, and well-defined neuroanatomical regions of interest is crucial to extrapolating finer discrepancies between primary and TBI-related depression.